The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
Inside the Market’s roundup of some of today’s key analyst actions
Bausch Health Companies Inc. (BHC-N, BHC-T) is likely to “change dramatically” over the next 12-18 months, according to RBC Dominion Securities’ Douglas Miehm, who thinks the market is “only starting to understand the value that could be surfaced.”
After being “on the sidelines for more than five years,” the equity analyst now sees the path to the expected spin off its eye-care business and thinks the “implications of possible divestitures provide near-term upside potential.”